Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction

Wook Ha Park, Dae Won Jun, Jin Taek Kim, Jae Hoon Jeong, Hyokeun Park, Yoon Seok Chang, Kyong Soo Park, Hong Kyu Lee, Youngmi Kim Pak

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Serum concentrations of environmental pollutants have been positively correlated with diabetes and metabolic syndrome in epidemiologic studies. In turn, abnormal mitochondrial function has been associated with the diseases. The relationships between these variables, however, have not been studied. We developed novel cell-based aryl hydrocarbon receptor (AhR) agonist bioassay system without solvent extraction process and analyzed whether low-dose circulating AhR ligands in human serum are associated with parameters of metabolic syndrome and mitochondrial function. Serum AhR ligand activities were measured as serum 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent (sTCDDeq) in pM using 10 μL human sera from 97 Korean participants (47 with glucose intolerance and 50 matched controls, average age of 46.6 ± 9.9 years, 53 male and 45 female). sTCDDeq were higher in participants with glucose intolerance than normal controls and were positively associated (P < 0.01) with obesity, blood pressure, serum triglyceride, and fasting glucose, but not with HDL-cholesterol. Body mass index was in a positive linear relationship with serum AhR ligands in healthy participants. When myoblast cells were incubated with human sera, ATP generating power of mitochondria became impaired in an AhR ligand concentration-dependent manner. Our results support that circulating AhR ligands may directly reduce mitochondrial function in tissues, leading to weight gain, glucose intolerance, and metabolic syndrome. Our rapid cell-based assay using minute volume of human serum may provide one of the best monitoring systems for circulating AhR ligands, good clinical biomarkers for the progress of disease and therapeutic efficacy.

Original languageEnglish (US)
Pages (from-to)494-504
Number of pages11
JournalBioFactors
Volume39
Issue number4
DOIs
StatePublished - Jul 1 2013
Externally publishedYes

Fingerprint

Aryl Hydrocarbon Receptors
Assays
Ligands
Serum
Glucose
Glucose Intolerance
Environmental Pollutants
Mitochondria
Bioassay
Blood pressure
Biomarkers
Solvent extraction
Medical problems
HDL Cholesterol
Triglycerides
Myoblasts
Adenosine Triphosphate
Tissue
Biological Assay
Weight Gain

Keywords

  • Alternative test method development
  • Aryl hydrocarbon receptor
  • Dioxins
  • Insulin resistance
  • Metabolic syndrome
  • Mitochondrial dysfunction
  • Obesity
  • POPs

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Park, W. H., Jun, D. W., Kim, J. T., Jeong, J. H., Park, H., Chang, Y. S., ... Pak, Y. K. (2013). Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction. BioFactors, 39(4), 494-504. https://doi.org/10.1002/biof.1092

Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction. / Park, Wook Ha; Jun, Dae Won; Kim, Jin Taek; Jeong, Jae Hoon; Park, Hyokeun; Chang, Yoon Seok; Park, Kyong Soo; Lee, Hong Kyu; Pak, Youngmi Kim.

In: BioFactors, Vol. 39, No. 4, 01.07.2013, p. 494-504.

Research output: Contribution to journalArticle

Park, WH, Jun, DW, Kim, JT, Jeong, JH, Park, H, Chang, YS, Park, KS, Lee, HK & Pak, YK 2013, 'Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction', BioFactors, vol. 39, no. 4, pp. 494-504. https://doi.org/10.1002/biof.1092
Park, Wook Ha ; Jun, Dae Won ; Kim, Jin Taek ; Jeong, Jae Hoon ; Park, Hyokeun ; Chang, Yoon Seok ; Park, Kyong Soo ; Lee, Hong Kyu ; Pak, Youngmi Kim. / Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction. In: BioFactors. 2013 ; Vol. 39, No. 4. pp. 494-504.
@article{e4ffe5cbfa8c4f1a83382bb3e4e8371a,
title = "Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction",
abstract = "Serum concentrations of environmental pollutants have been positively correlated with diabetes and metabolic syndrome in epidemiologic studies. In turn, abnormal mitochondrial function has been associated with the diseases. The relationships between these variables, however, have not been studied. We developed novel cell-based aryl hydrocarbon receptor (AhR) agonist bioassay system without solvent extraction process and analyzed whether low-dose circulating AhR ligands in human serum are associated with parameters of metabolic syndrome and mitochondrial function. Serum AhR ligand activities were measured as serum 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent (sTCDDeq) in pM using 10 μL human sera from 97 Korean participants (47 with glucose intolerance and 50 matched controls, average age of 46.6 ± 9.9 years, 53 male and 45 female). sTCDDeq were higher in participants with glucose intolerance than normal controls and were positively associated (P < 0.01) with obesity, blood pressure, serum triglyceride, and fasting glucose, but not with HDL-cholesterol. Body mass index was in a positive linear relationship with serum AhR ligands in healthy participants. When myoblast cells were incubated with human sera, ATP generating power of mitochondria became impaired in an AhR ligand concentration-dependent manner. Our results support that circulating AhR ligands may directly reduce mitochondrial function in tissues, leading to weight gain, glucose intolerance, and metabolic syndrome. Our rapid cell-based assay using minute volume of human serum may provide one of the best monitoring systems for circulating AhR ligands, good clinical biomarkers for the progress of disease and therapeutic efficacy.",
keywords = "Alternative test method development, Aryl hydrocarbon receptor, Dioxins, Insulin resistance, Metabolic syndrome, Mitochondrial dysfunction, Obesity, POPs",
author = "Park, {Wook Ha} and Jun, {Dae Won} and Kim, {Jin Taek} and Jeong, {Jae Hoon} and Hyokeun Park and Chang, {Yoon Seok} and Park, {Kyong Soo} and Lee, {Hong Kyu} and Pak, {Youngmi Kim}",
year = "2013",
month = "7",
day = "1",
doi = "10.1002/biof.1092",
language = "English (US)",
volume = "39",
pages = "494--504",
journal = "BioFactors",
issn = "0951-6433",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction

AU - Park, Wook Ha

AU - Jun, Dae Won

AU - Kim, Jin Taek

AU - Jeong, Jae Hoon

AU - Park, Hyokeun

AU - Chang, Yoon Seok

AU - Park, Kyong Soo

AU - Lee, Hong Kyu

AU - Pak, Youngmi Kim

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Serum concentrations of environmental pollutants have been positively correlated with diabetes and metabolic syndrome in epidemiologic studies. In turn, abnormal mitochondrial function has been associated with the diseases. The relationships between these variables, however, have not been studied. We developed novel cell-based aryl hydrocarbon receptor (AhR) agonist bioassay system without solvent extraction process and analyzed whether low-dose circulating AhR ligands in human serum are associated with parameters of metabolic syndrome and mitochondrial function. Serum AhR ligand activities were measured as serum 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent (sTCDDeq) in pM using 10 μL human sera from 97 Korean participants (47 with glucose intolerance and 50 matched controls, average age of 46.6 ± 9.9 years, 53 male and 45 female). sTCDDeq were higher in participants with glucose intolerance than normal controls and were positively associated (P < 0.01) with obesity, blood pressure, serum triglyceride, and fasting glucose, but not with HDL-cholesterol. Body mass index was in a positive linear relationship with serum AhR ligands in healthy participants. When myoblast cells were incubated with human sera, ATP generating power of mitochondria became impaired in an AhR ligand concentration-dependent manner. Our results support that circulating AhR ligands may directly reduce mitochondrial function in tissues, leading to weight gain, glucose intolerance, and metabolic syndrome. Our rapid cell-based assay using minute volume of human serum may provide one of the best monitoring systems for circulating AhR ligands, good clinical biomarkers for the progress of disease and therapeutic efficacy.

AB - Serum concentrations of environmental pollutants have been positively correlated with diabetes and metabolic syndrome in epidemiologic studies. In turn, abnormal mitochondrial function has been associated with the diseases. The relationships between these variables, however, have not been studied. We developed novel cell-based aryl hydrocarbon receptor (AhR) agonist bioassay system without solvent extraction process and analyzed whether low-dose circulating AhR ligands in human serum are associated with parameters of metabolic syndrome and mitochondrial function. Serum AhR ligand activities were measured as serum 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalent (sTCDDeq) in pM using 10 μL human sera from 97 Korean participants (47 with glucose intolerance and 50 matched controls, average age of 46.6 ± 9.9 years, 53 male and 45 female). sTCDDeq were higher in participants with glucose intolerance than normal controls and were positively associated (P < 0.01) with obesity, blood pressure, serum triglyceride, and fasting glucose, but not with HDL-cholesterol. Body mass index was in a positive linear relationship with serum AhR ligands in healthy participants. When myoblast cells were incubated with human sera, ATP generating power of mitochondria became impaired in an AhR ligand concentration-dependent manner. Our results support that circulating AhR ligands may directly reduce mitochondrial function in tissues, leading to weight gain, glucose intolerance, and metabolic syndrome. Our rapid cell-based assay using minute volume of human serum may provide one of the best monitoring systems for circulating AhR ligands, good clinical biomarkers for the progress of disease and therapeutic efficacy.

KW - Alternative test method development

KW - Aryl hydrocarbon receptor

KW - Dioxins

KW - Insulin resistance

KW - Metabolic syndrome

KW - Mitochondrial dysfunction

KW - Obesity

KW - POPs

UR - http://www.scopus.com/inward/record.url?scp=84881662568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881662568&partnerID=8YFLogxK

U2 - 10.1002/biof.1092

DO - 10.1002/biof.1092

M3 - Article

C2 - 23361953

AN - SCOPUS:84881662568

VL - 39

SP - 494

EP - 504

JO - BioFactors

JF - BioFactors

SN - 0951-6433

IS - 4

ER -